90.4% The good thing about this is that SK Bioscience can produce consignment products, so Korea doesn’t have to worry about vaccines.
Novavax Clinical Phase 3 Results
90.4% The good thing about this is that SK Bioscience can produce consignment products, so Korea doesn’t have to worry about vaccines.